Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios G Papavassiliou

Showing results (31-40 of 522) with videos related to

Pageof 53
Sort By:
Clinical Breast Cancer|October 19, 2017
Epigenetic Pathways Offer Targets for Ovarian Cancer TreatmentMelina-Theoni Gyparaki, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|February 17, 2007
Targeting the nerve growth factor network in Alzheimer's diseaseGerasimos P Sykiotis, Athanasios G Papavassiliou
The New England Journal of Medicine|January 6, 2007
The tuberous sclerosis complexPanagiotis A Konstantinopoulos, Athanasios G Papavassiliou
Biomedicines|December 24, 2021
The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Molecular Medicine|October 12, 2005
Molecular medicine: a lifetime of learning, teaching and caringGerasimos P Sykiotis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|November 12, 2013
Histone deacetylases inhibitors: conjugation to other anti-tumour pharmacophores provides novel tools for cancer treatmentKonstantinos A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular and Molecular Medicine|June 1, 2024
Suv39h1: Targeting epigenetics to treat liver fibrosisKostas A Papavassiliou, Athanasios G Papavassiliou
Neuromolecular Medicine|February 14, 2014
Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseGeorgia S Gaki, Athanasios G Papavassiliou
Trends in Molecular Medicine|July 3, 2014
Bromodomains: pockets with therapeutic potentialKostas A Papavassiliou, Athanasios G Papavassiliou
Cell Metabolism|June 5, 2024
Hungry for fat: Metabolic crosstalk with lipid-rich CAFs fuels pancreatic cancerKostas A Papavassiliou, Athanasios G Papavassiliou
Pageof 53

Showing results (31-40 of 522) with videos related to

Sort By:
Pageof 53
Clinical Breast Cancer|October 19, 2017
Epigenetic Pathways Offer Targets for Ovarian Cancer TreatmentMelina-Theoni Gyparaki, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|February 17, 2007
Targeting the nerve growth factor network in Alzheimer's diseaseGerasimos P Sykiotis, Athanasios G Papavassiliou
The New England Journal of Medicine|January 6, 2007
The tuberous sclerosis complexPanagiotis A Konstantinopoulos, Athanasios G Papavassiliou
Biomedicines|December 24, 2021
The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Molecular Medicine|October 12, 2005
Molecular medicine: a lifetime of learning, teaching and caringGerasimos P Sykiotis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|November 12, 2013
Histone deacetylases inhibitors: conjugation to other anti-tumour pharmacophores provides novel tools for cancer treatmentKonstantinos A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular and Molecular Medicine|June 1, 2024
Suv39h1: Targeting epigenetics to treat liver fibrosisKostas A Papavassiliou, Athanasios G Papavassiliou
Neuromolecular Medicine|February 14, 2014
Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseGeorgia S Gaki, Athanasios G Papavassiliou
Trends in Molecular Medicine|July 3, 2014
Bromodomains: pockets with therapeutic potentialKostas A Papavassiliou, Athanasios G Papavassiliou
Cell Metabolism|June 5, 2024
Hungry for fat: Metabolic crosstalk with lipid-rich CAFs fuels pancreatic cancerKostas A Papavassiliou, Athanasios G Papavassiliou
Pageof 53